Equity Research, Broker Reports, and media content on Allergy Therapeutics plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Allergy Therapeutics plc

Company Profile

  • Personnel
  • Manuel Llobet , CEO
  • Nicolas Wykeman, Finance Director

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics plc. We currently have 250 research reports from 11 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 7.00/21.9p
  • Daily Volume: N/A
  • Daily Liquidity: (0.05%)
  • # Shares: 637.3m
  • Market Cap: £125.0m
  • Latest PE (hist): 23.36
  • Div Yield:
Date Source Announcement
13Jan21 07:00 RNS Half Year Trading Update 2021 & Notice of Results
08Jan21 16:41 RNS Second Price Monitoring Extn
08Jan21 16:36 RNS Price Monitoring Extension
05Jan21 07:00 RNS Initiation of peanut allergy biomarker study
14Dec20 15:58 RNS Director/PDMR Shareholding
08Dec20 14:42 RNS Result of Annual General Meeting
20Nov20 13:51 RNS Grant of Awards under Long Term Incentive Plan
  • Frequency of research reports

     

  • Research reports on

    Allergy Therapeutics plc

  • Providers covering

    Allergy Therapeutics plc